United Kingdom· GB-APID-44874111000001108
Altuvoct 4,000unit powder and solvent for solution for injection vials
A efanesoctocog alfa product containing efanesoctocog alfa, registered in United Kingdom by Swedish Orphan Biovitrum Ltd. The same ATC class is registered in 2 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Efanesoctocog alfa is registered in 2 of 19 countries.
Countries holding a registration under ATC B02BD45 (efanesoctocog alfa), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 1 of them publish a price we can compare per daily dose
Efanesoctocog alfa · ATC B02BD45
2 / 19 countries
- Franceprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Efanesoctocog alfa
- Manufacturer
- Swedish Orphan Biovitrum Ltd
- Country
- United Kingdom (GB)
- ATC code
- B02BD45
- ATC class
- Efanesoctocog alfa
- Defined daily dose
- 500 E, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin07350031445091
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Efanesoctocog alfa in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandALTUVOCTOrifarm Oy
- SwitzerlandAltuvoct
- CzechiaALTUVOCTSwedish Orphan Biovitrum AB (publ), Stockholm
- SpainALTUVOCT 1 000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLESwedish Orphan Biovitrum Ab (Publ)
- SwedenALTUVOCT 1000 IE Pulver och vätska till injektionsvätska, lösningSwedish Orphan Biovitrum AB (publ)
- NorwayAltuvoctSwedish Orphan Biovitrum AB
- PolandAltuvoctSwedish Orphan Biovitrum AB (publ)
- BelgiumAltuvoct 1000 IUSwedish Orphan Biovitrum (Publ)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Altuvoct
- Liechtenstein · Altuvoct
- Norway · Altuvoct
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bfd4520b-3083-4233-9de9-d09a665a14f1 GET /v1/drugs/bfd4520b-3083-4233-9de9-d09a665a14f1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "44874111000001108",
"desc": "Altuvoct 4,000unit powder and solvent for solution for injection vials (Swedish Orphan Biovitrum Ltd)",
"form": "Powder and solvent for solution for injection",
"vpid": "44923611000001107",
"source": "dmd",
"vtm_id": "44913211000001101",
"strength": "4000 unit",
"substance": "Efanesoctocog alfa",
"ingredient": "Efanesoctocog alfa",
"supplier_code": "4232111000001108"
}See everything about efanesoctocog alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.